Irritable Bowel Syndrome and Digestive Health Support Forum banner
1-1 of 1 Results
  1. IBS News, Media, Research, Discussion or Abstracts
    The US Food and Drug Administration (FDA) has approved Sucampo's supplemental new drug application (sNDA) for AMITIZA®(lubiprostone) (24 mcg twice daily) as the first and only oral medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain...
1-1 of 1 Results